메뉴 건너뛰기




Volumn 152, Issue 2, 2011, Pages 310-316

Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity

Author keywords

PGA nanoparticle; Antigen delivery carrier; Intranasal vaccination; Tumor immunity

Indexed keywords

AMPHIPHILICS; ANTI-TUMOR ACTIVITIES; ANTI-TUMOR EFFICACY; ANTIGEN DELIVERY; ANTIGEN-DELIVERY CARRIER; CANCER VACCINE; CERVICAL LYMPH NODES; CYTOTOXIC T LYMPHOCYTES; GLUTAMIC ACID; IMMUNE RESPONSE; INTRANASAL; LUNG METASTASIS; LYMPH NODE; LYMPHOID TISSUE; NASAL CAVITY; NASAL VACCINATION; NON-INVASIVE; OVALBUMINS; TUMOR CELLS;

EID: 79958245618     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.03.009     Document Type: Article
Times cited : (53)

References (21)
  • 1
    • 6944244084 scopus 로고    scopus 로고
    • A module map showing conditional activity of expression modules in cancer
    • DOI 10.1038/ng1434
    • E. Segal, N. Friedman, D. Koller, and A. Regev A module map showing conditional activity of expression modules in cancer Nat. Genet. 36 10 2004 1090 1098 (Pubitemid 41184471)
    • (2004) Nature Genetics , vol.36 , Issue.10 , pp. 1090-1098
    • Segal, E.1    Friedman, N.2    Koller, D.3    Regev, A.4
  • 2
    • 33750605893 scopus 로고    scopus 로고
    • Tumor-associated antigen arrays for the serological diagnosis of cancer
    • DOI 10.1074/mcp.R600010-MCP200
    • C.A. Casiano, M. Mediavilla-Varela, and E.M. Tan Tumor-associated antigen arrays for the serological diagnosis of cancer Mol. Cell. Proteomics 5 10 2006 1745 1759 (Pubitemid 44688185)
    • (2006) Molecular and Cellular Proteomics , vol.5 , Issue.10 , pp. 1745-1759
    • Casiano, C.A.1    Mediavilla-Varela, M.2    Tan, E.M.3
  • 4
    • 0037818503 scopus 로고    scopus 로고
    • Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
    • DOI 10.1182/blood-2002-08-2554
    • S.M. Schmidt, K. Schag, M.R. Müller, M.M. Weck, S. Appel, L. Kanz, F. Grünebach, and P. Brossart Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells Blood 102 2 2003 571 576 (Pubitemid 36841977)
    • (2003) Blood , vol.102 , Issue.2 , pp. 571-576
    • Schmidt, S.M.1    Schag, K.2    Muller, M.R.3    Weck, M.M.4    Appel, S.5    Kanz, L.6    Grunebach, F.7    Brossart, P.8
  • 7
    • 33644831362 scopus 로고    scopus 로고
    • Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
    • H. Shen, A.L. Ackerman, V. Cody, A. Giodini, E.R. Hinson, P. Cresswell, R.L. Edelson, W.M. Saltzman, and D.J. Hanlon Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles Immunology 117 1 2006 78 88
    • (2006) Immunology , vol.117 , Issue.1 , pp. 78-88
    • Shen, H.1    Ackerman, A.L.2    Cody, V.3    Giodini, A.4    Hinson, E.R.5    Cresswell, P.6    Edelson, R.L.7    Saltzman, W.M.8    Hanlon, D.J.9
  • 8
    • 21744448012 scopus 로고    scopus 로고
    • Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
    • DOI 10.1016/j.jconrel.2005.02.027, PII S0168365905000969
    • Y.J. Kwon, S.M. Standley, S.L. Goh, and J.M. Fréchet Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles J. Control. Release 105 3 2005 199 212 (Pubitemid 40941986)
    • (2005) Journal of Controlled Release , vol.105 , Issue.3 , pp. 199-212
    • Kwon, Y.J.1    Standley, S.M.2    Goh, S.L.3    Frechet, J.M.J.4
  • 10
    • 27744580069 scopus 로고    scopus 로고
    • Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with L-phenylalanine as a protein carrier
    • DOI 10.1016/j.jconrel.2005.08.003, PII S0168365905003573
    • T. Akagi, T. Kaneko, T. Kida, and M. Akashi Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier J. Control. Release 108 2-3 2005 226 236 (Pubitemid 41608656)
    • (2005) Journal of Controlled Release , vol.108 , Issue.2-3 , pp. 226-236
    • Akagi, T.1    Kaneko, T.2    Kida, T.3    Akashi, M.4
  • 11
    • 39249084875 scopus 로고    scopus 로고
    • Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: A new tumor-vaccine carrier for eliciting effector T cells
    • T. Yoshikawa, N. Okada, A. Oda, K. Matsuo, K. Matsuo, H. Kayamuro, Y. Ishii, T. Yoshinaga, T. Akagi, M. Akashi, and S. Nakagawa Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells Vaccine 26 10 2008 1303 1313
    • (2008) Vaccine , vol.26 , Issue.10 , pp. 1303-1313
    • Yoshikawa, T.1    Okada, N.2    Oda, A.3    Matsuo, K.4    Matsuo, K.5    Kayamuro, H.6    Ishii, Y.7    Yoshinaga, T.8    Akagi, T.9    Akashi, M.10    Nakagawa, S.11
  • 12
    • 0032724112 scopus 로고    scopus 로고
    • Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma
    • F. Wang, E. Bade, C. Kuniyoshi, L. Spears, G. Jeffery, V. Marty, S. Groshen, and J. Weber Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma Clin. Cancer Res. 5 10 1999 2756 2765 (Pubitemid 29493949)
    • (1999) Clinical Cancer Research , vol.5 , Issue.10 , pp. 2756-2765
    • Wang, F.1    Bade, E.2    Kuniyoshi, C.3    Spears, L.4    Jeffery, G.5    Marty, V.6    Groshen, S.7    Weber, J.8
  • 13
    • 0028116790 scopus 로고
    • Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation
    • Y. Li, Y. Ke, P.D. Gottlieb, and J.A. Kapp Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation J. Leukoc. Biol. 56 5 1994 616 624 (Pubitemid 24348822)
    • (1994) Journal of Leukocyte Biology , vol.56 , Issue.5 , pp. 616-624
    • Li, Y.1    Ke, Y.2    Gottlieb, P.D.3    Kapp, J.A.4
  • 14
    • 0028052101 scopus 로고
    • Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules
    • C.V. Harding, and R. Song Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules J. Immunol. 153 11 1994 4925 4933 (Pubitemid 24356123)
    • (1994) Journal of Immunology , vol.153 , Issue.11 , pp. 4925-4933
    • Harding, C.V.1    Song, R.2
  • 15
    • 0036876410 scopus 로고    scopus 로고
    • Type 1 and type 2 responses in regulation of Ig isotype expression in cattle
    • DOI 10.1016/S0165-2427(02)00201-5, PII S0165242702002015
    • D.M. Estes, and W.C. Brown Type 1 and type 2 responses in regulation of Ig isotype expression in cattle Vet. Immunol. Immunopathol. 90 1-2 2002 1 10 (Pubitemid 36160480)
    • (2002) Veterinary Immunology and Immunopathology , vol.90 , Issue.1-2 , pp. 1-10
    • Estes, D.M.1    Brown, W.C.2
  • 16
    • 0032520727 scopus 로고    scopus 로고
    • The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice
    • DOI 10.1016/S0022-1759(98)00015-5, PII S0022175998000155
    • R.M. Martin, J.L. Brady, and A.M. Lew The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice J. Immunol. Meth. 212 2 1998 187 192 (Pubitemid 28288356)
    • (1998) Journal of Immunological Methods , vol.212 , Issue.2 , pp. 187-192
    • Martin, R.M.1    Brady, J.L.2    Lew, A.M.3
  • 17
    • 0035052853 scopus 로고    scopus 로고
    • Tumours can act as adjuvants for humoral immunity
    • DOI 10.1046/j.1365-2567.2001.01213.x
    • D.M. Brown, T.L. Fisher, C. Wei, J.G. Frelinger, and E.M. Lord Tumours can act as adjuvants for humoral immunity Immunology 102 4 2001 486 497 (Pubitemid 32322961)
    • (2001) Immunology , vol.102 , Issue.4 , pp. 486-497
    • Brown, D.M.1    Fisher, T.L.2    Wei, C.3    Frelinger, J.G.4    Lord, E.M.5
  • 20
    • 0037223094 scopus 로고    scopus 로고
    • HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses
    • G. Sakaue, T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses J. Immunol. 170 1 2003 495 502 (Pubitemid 36026176)
    • (2003) Journal of Immunology , vol.170 , Issue.1 , pp. 495-502
    • Sakaue, G.1    Hiroi, T.2    Nakagawa, Y.3    Someya, K.4    Iwatani, K.5    Sawa, Y.6    Takahashi, H.7    Honda, M.8    Kunisawa, J.9    Kiyono, H.10
  • 21
    • 4544258068 scopus 로고    scopus 로고
    • Nalt-versus Peyer's-patch-mediated mucosal immunity
    • DOI 10.1038/nri1439
    • H. Kiyono, and S. Fukuyama NALT- versus Peyer's-patch-mediated mucosal immunity Nat. Rev. Immunol. 4 9 2004 699 710 (Pubitemid 39223076)
    • (2004) Nature Reviews Immunology , vol.4 , Issue.9 , pp. 699-710
    • Kiyono, H.1    Fukuyama, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.